FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149346040> ?p ?o ?g. }

• W2149346040 endingPage "6531" @default.
• W2149346040 startingPage "6523" @default.
• W2149346040 abstract "Abstract Purpose: A dual-regulated adenovirus variant CNHK500, in which human telomerase reverse transcriptase promoter drove the adenovirus 5 (Ad5) E1a gene and hypoxia-response promoter controlled the E1b gene, was engineered. This virus has broad anticancer spectrum and higher specificity compared with mono-regulated adenovirus CNHK300. The objective of the current study is to show its antitumor selectivity and therapeutic potential. Experimental Design: The antitumor specificity of human telomerase reverse transcriptase and hypoxia response promoters was evaluated in a panel of tumor and normal cells. Under the control of these promoters, the tumor-selective expression of E1a and E1b genes was evaluated. Further in vitro antitumor specificity and potency of this virus were characterized by viral replication and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Subsequently, hepatocellular carcinoma xenografts were established to evaluate CNHK500 antitumor efficacy in vivo by different routes of virus administration and different dosages. Results: Human telomerase reverse transcriptase and hypoxia response promoters were activated in a tumor-selective manner or under hypoxia treatment in a broad panel of cells. Selective adenoviral early gene expression, efficient viral replication, and oncolysis were observed in all tested cancer cells with more attenuated replication capacity in normal cells. Significant regression of hepatocellular carcinoma xenografts and prolonged survival were observed by either i.t. or i.v. administration. Conclusions: CNHK500 greatly reduced side effects in normal cells via dual control of adenoviral essential genes while still preserving potent antitumor efficacy on broad-spectrum cancer cells in vitro and in vivo. It can be used as a powerful therapeutic agent not only for liver cancers but also for other solid tumors." @default.
• W2149346040 created "2016-06-24" @default.
• W2149346040 creator A5003360183 @default.
• W2149346040 creator A5019115888 @default.
• W2149346040 creator A5021956636 @default.
• W2149346040 creator A5026984704 @default.
• W2149346040 creator A5031174810 @default.
• W2149346040 creator A5034676224 @default.
• W2149346040 creator A5038495172 @default.
• W2149346040 creator A5044871527 @default.
• W2149346040 creator A5048211111 @default.
• W2149346040 creator A5049692788 @default.
• W2149346040 creator A5083665738 @default.
• W2149346040 creator A5090394529 @default.
• W2149346040 date "2006-11-01" @default.
• W2149346040 modified "2023-09-24" @default.
• W2149346040 title "Increased Safety with Preserved Antitumoral Efficacy on Hepatocellular Carcinoma with Dual-Regulated Oncolytic Adenovirus" @default.
• W2149346040 cites W1558969188 @default.
• W2149346040 cites W1591201444 @default.
• W2149346040 cites W1971296225 @default.
• W2149346040 cites W1981218816 @default.
• W2149346040 cites W1986969117 @default.
• W2149346040 cites W1989154791 @default.
• W2149346040 cites W1992116006 @default.
• W2149346040 cites W1994676214 @default.
• W2149346040 cites W1999844985 @default.
• W2149346040 cites W2010955901 @default.
• W2149346040 cites W2011810742 @default.
• W2149346040 cites W2016647287 @default.
• W2149346040 cites W2020222773 @default.
• W2149346040 cites W2027873984 @default.
• W2149346040 cites W2027894741 @default.
• W2149346040 cites W2032743024 @default.
• W2149346040 cites W2036473538 @default.
• W2149346040 cites W2037292820 @default.
• W2149346040 cites W2053059248 @default.
• W2149346040 cites W2053621712 @default.
• W2149346040 cites W2053888572 @default.
• W2149346040 cites W2064796491 @default.
• W2149346040 cites W2066475295 @default.
• W2149346040 cites W2077895443 @default.
• W2149346040 cites W2088033621 @default.
• W2149346040 cites W2091781047 @default.
• W2149346040 cites W2094107270 @default.
• W2149346040 cites W2109415128 @default.
• W2149346040 cites W2115459972 @default.
• W2149346040 cites W2120867214 @default.
• W2149346040 cites W2125980219 @default.
• W2149346040 cites W2150163937 @default.
• W2149346040 cites W2156592372 @default.
• W2149346040 cites W2156653943 @default.
• W2149346040 cites W2178256888 @default.
• W2149346040 doi "https://doi.org/10.1158/1078-0432.ccr-06-1491" @default.
• W2149346040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17085667" @default.
• W2149346040 hasPublicationYear "2006" @default.
• W2149346040 type Work @default.
• W2149346040 sameAs 2149346040 @default.
• W2149346040 citedByCount "44" @default.
• W2149346040 countsByYear W21493460402012 @default.
• W2149346040 countsByYear W21493460402013 @default.
• W2149346040 countsByYear W21493460402015 @default.
• W2149346040 countsByYear W21493460402016 @default.
• W2149346040 countsByYear W21493460402017 @default.
• W2149346040 countsByYear W21493460402018 @default.
• W2149346040 countsByYear W21493460402019 @default.
• W2149346040 countsByYear W21493460402020 @default.
• W2149346040 countsByYear W21493460402021 @default.
• W2149346040 countsByYear W21493460402022 @default.
• W2149346040 countsByYear W21493460402023 @default.
• W2149346040 crossrefType "journal-article" @default.
• W2149346040 hasAuthorship W2149346040A5003360183 @default.
• W2149346040 hasAuthorship W2149346040A5019115888 @default.
• W2149346040 hasAuthorship W2149346040A5021956636 @default.
• W2149346040 hasAuthorship W2149346040A5026984704 @default.
• W2149346040 hasAuthorship W2149346040A5031174810 @default.
• W2149346040 hasAuthorship W2149346040A5034676224 @default.
• W2149346040 hasAuthorship W2149346040A5038495172 @default.
• W2149346040 hasAuthorship W2149346040A5044871527 @default.
• W2149346040 hasAuthorship W2149346040A5048211111 @default.
• W2149346040 hasAuthorship W2149346040A5049692788 @default.
• W2149346040 hasAuthorship W2149346040A5083665738 @default.
• W2149346040 hasAuthorship W2149346040A5090394529 @default.
• W2149346040 hasConcept C101762097 @default.
• W2149346040 hasConcept C104317684 @default.
• W2149346040 hasConcept C111599444 @default.
• W2149346040 hasConcept C121608353 @default.
• W2149346040 hasConcept C125593758 @default.
• W2149346040 hasConcept C140704245 @default.
• W2149346040 hasConcept C150194340 @default.
• W2149346040 hasConcept C150903083 @default.
• W2149346040 hasConcept C153911025 @default.
• W2149346040 hasConcept C159047783 @default.
• W2149346040 hasConcept C207001950 @default.
• W2149346040 hasConcept C2522874641 @default.
• W2149346040 hasConcept C2776954459 @default.
• W2149346040 hasConcept C2777283488 @default.
• W2149346040 hasConcept C2778019345 @default.
• W2149346040 hasConcept C49744831 @default.

• next